A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease
- PMID: 177449
- DOI: 10.1210/jcem-42-4-778
A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease
Abstract
Several assays for thyroid-stimulating immunoglobulins in the blood in patients with Graves' disease have been described recently; depending upon the method, different names have been used and distinct entities thus implied. Using an increase in cyclic AMP in the human thyroid slice after 2 h of incubation as an index of thyroid stimulation, we identified thyroid-stimulating activity in all of an unselected series of sera from 11 patients with hyperthyroidism of Graves' disease, but long-acting thyroid stimulator, by mouse bioassay, in only three. The theory is proposed that the thyroid-stimulating immunoglobulin is probably present in all such patients; it may be seen as a polyclonal antibody to a single human antigen that has a variable cross-reaction with a corresponding thyroid antigen in the mouse and in other species.
Similar articles
-
Thyroid stimulating immunoglobulin in Graves' disease.Aust N Z J Med. 1981 Jun;11(3):293-8. Aust N Z J Med. 1981. PMID: 6170289
-
Proceedings: Influence of human thyroid-stimulating hormone and immunoglobulins from patients with Graves' disease on human thyroid cyclic AMP.J Endocrinol. 1976 Jun;69(3):8P-9P. J Endocrinol. 1976. PMID: 181521 No abstract available.
-
Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI).J Clin Endocrinol Metab. 1976 Aug;43(2):330-7. doi: 10.1210/jcem-43-2-330. J Clin Endocrinol Metab. 1976. PMID: 181397
-
LATS in Graves' disease.Recent Prog Horm Res. 1976;33:29-57. doi: 10.1016/b978-0-12-571133-3.50009-x. Recent Prog Horm Res. 1976. PMID: 198858 Review. No abstract available.
-
Pathogenesis of hyperthyroidism.Annu Rev Med. 1983;34:267-81. doi: 10.1146/annurev.me.34.020183.001411. Annu Rev Med. 1983. PMID: 6134495 Review.
Cited by
-
Prognostic factors for thyroid-stimulating immunoglobulin normalization in moderate-to-severe Graves' orbitopathy: a 36-month longitudinal study.BMC Ophthalmol. 2024 Aug 21;24(1):361. doi: 10.1186/s12886-024-03594-4. BMC Ophthalmol. 2024. PMID: 39169342 Free PMC article.
-
Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo.J Endocrinol Invest. 1984 Feb;7(1):1-6. doi: 10.1007/BF03348367. J Endocrinol Invest. 1984. PMID: 6325527
-
Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.Clin Exp Immunol. 1984 Sep;57(3):633-8. Clin Exp Immunol. 1984. PMID: 6147216 Free PMC article.
-
Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.J Endocrinol Invest. 1982 Sep-Oct;5(5):293-301. doi: 10.1007/BF03350517. J Endocrinol Invest. 1982. PMID: 6296219
-
Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema.J Endocrinol Invest. 1982 Nov-Dec;5(6):373-8. doi: 10.1007/BF03350535. J Endocrinol Invest. 1982. PMID: 6132943
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources